Tyra Biosciences, Inc. TYRA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$119.95M-38.7% | -$86.48M-25.1% | -$69.13M-25.0% | -$55.33M-110% | ||
| $546K+5.2% | $519K+45.4% | $357K+20.6% | $296K+111% | ||
| $28.01M+22.8% | $22.8M+68.6% | $13.53M+27.7% | $10.59M+267% | ||
| -$95.14M-36.4% | -$69.77M-39.2% | -$50.14M+0.3% | -$50.29M-112% | ||
| $141K-78.8% | $664K-13.8% | $770K+37.7% | $559K-15.4% | ||
| —— | —— | -$144.61M-25,769% | -$559K+13.3% | ||
| $8.1M-96.0% | $202.14M+13,051% | $1.54M+143% | $632K— | ||
| —— | —— | -$193.21M-285% | -$50.21M— | ||
| -$95.28M-35.3% | -$70.44M-38.4% | -$50.91M-0.1% | -$50.84M-108% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Tyra Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.